Price
Financials
Standalone, Rs crore| Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.05 | 24.04 | 30.86 | 32.89 | 35.10 | 35.66 | 44.85 | 46.06 | 45.03 | 47.34 |
| Expenses | 16.04 | 20.05 | 24.06 | 25.90 | 28.64 | 28.63 | 35.94 | 35.95 | 37.17 | 37.92 |
| Operating Profit | 4.01 | 3.99 | 6.80 | 6.99 | 6.46 | 7.03 | 8.91 | 10.11 | 7.86 | 9.42 |
| OPM % | 20.00% | 16.60% | 22.03% | 21.25% | 18.40% | 19.71% | 19.87% | 21.95% | 17.46% | 19.90% |
| Other Income | 1.20 | -0.41 | 1.13 | 0.89 | 3.66 | 1.42 | 0.80 | 1.50 | 0.67 | 0.59 |
| Interest | 0.60 | 0.76 | 0.76 | 1.18 | 1.35 | 1.22 | 1.07 | 1.25 | 0.71 | 1.17 |
| Depreciation | 3.25 | 3.49 | 3.18 | 3.04 | 3.23 | 2.96 | 2.88 | 2.86 | 2.74 | 3.13 |
| Profit before tax | 1.36 | -0.67 | 3.99 | 3.66 | 5.54 | 4.27 | 5.76 | 7.50 | 5.08 | 5.71 |
| Tax % | 102.94% | -76.12% | 27.07% | 25.41% | 30.87% | 25.29% | 25.17% | 27.07% | 19.49% | 25.22% |
| Net Profit | -0.05 | -0.16 | 2.90 | 2.72 | 3.83 | 3.20 | 4.30 | 5.48 | 4.09 | 4.27 |
| EPS in Rs | -0.03 | -0.08 | 1.47 | 1.38 | 1.95 | 1.63 | 2.19 | 2.78 | 2.08 | 2.17 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 43 | 54 | 65 | 69 | 81 | 118 | 173 | 183 |
| Expenses | 37 | 46 | 54 | 55 | 65 | 93 | 138 | 147 |
| Operating Profit | 6 | 8 | 11 | 14 | 16 | 25 | 36 | 36 |
| OPM % | 15% | 15% | 17% | 20% | 20% | 21% | 20% | 20% |
| Other Income | 0 | 0 | 1 | 2 | 2 | 6 | 3 | 4 |
| Interest | 1 | 1 | 1 | 1 | 3 | 4 | 4 | 4 |
| Depreciation | 2 | 3 | 3 | 4 | 9 | 13 | 11 | 12 |
| Profit before tax | 4 | 5 | 8 | 11 | 6 | 15 | 23 | 24 |
| Tax % | 27% | 26% | 26% | 26% | 33% | 25% | 24% | |
| Net Profit | 3 | 4 | 6 | 8 | 4 | 11 | 17 | 18 |
| EPS in Rs | 21.48 | 28.83 | 46.79 | 5.53 | 2.14 | 5.58 | 8.68 | 9.22 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 26% | 36% | 36% | ||
| Compounded Profit Growth | % | 37% | 29% | 43% | ||
| Stock Price CAGR | % | % | 20% | 46% | ||
| Return on Equity | % | 17% | 14% | 19% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 14 | 20 | 20 | 20 |
| Reserves | 12 | 16 | 21 | 27 | 51 | 62 | 79 |
| Borrowings | 5 | 7 | 12 | 17 | 32 | 49 | 58 |
| Other Liabilities | 9 | 13 | 28 | 34 | 52 | 34 | 38 |
| Total Liabilities | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
| Fixed Assets | 18 | 22 | 31 | 39 | 94 | 101 | 108 |
| CWIP | 0 | 2 | 9 | 18 | 0 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 9 | 13 | 22 | 37 | 60 | 61 | 84 |
| Total Assets | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 2 | 10 | 9 | 7 | 26 | -4 | 19 |
| Cash from Investing Activity | -5 | -16 | -23 | -21 | -63 | -8 | -19 |
| Cash from Financing Activity | 2 | 6 | 14 | 15 | 36 | 13 | 5 |
| Net Cash Flow | 0 | 0 | -0 | 1 | -1 | 1 | 5 |
| Free Cash Flow | -5 | 2 | -10 | -13 | -20 | -14 | 1 |
| CFO/OP | 62% | 142% | 104% | 73% | 162% | -3% | 69% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 14 | 30 | 90 | 109 | 123 | 114 |
| Inventory Days | 23 | 13 | 16 | 26 | 32 | 30 | 30 |
| Days Payable | 156 | 23 | 34 | 91 | 445 | 167 | 156 |
| Cash Conversion Cycle | -113 | 5 | 11 | 25 | -304 | -13 | -12 |
| Working Capital Days | -10 | -38 | -36 | 18 | 3 | 5 | 19 |
| ROCE % | 25% | 29% | 26% | 11% | 16% | 19% |
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.10% | 0.05% | 0.00% | 0.00% | 0.00% |
| DIIs | 3.26% | 2.33% | 1.95% | 2.92% | 3.19% | 2.18% | 1.98% | 2.40% | 2.97% |
| Public | 35.58% | 36.50% | 36.89% | 35.92% | 35.55% | 36.59% | 36.86% | 36.44% | 35.87% |
| No. of Shareholders | 706 | 1,261 | 1,284 | 1,262 | 1,176 | 1,167 | 1,225 | 1,316 | 1,399 |
Fundamentals
Market Cap₹ 372 Cr.
Current Price₹ 189
Stock P/E20.5
Book Value₹ 52.2
ROCE18.8 %
ROE19.0 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)36%
Compounded Profit Growth (TTM)43%
Standalone figures.
Valuation
Market capRs 257 Cr
Enterprise valueRs 265 Cr
P/E (TTM)14.15x
Price to book6.13x
Price to sales1.40x
EV / EBITDA6.66x
EV / EBIT9.39x
EV / sales1.45x
Price to cash flow35.01x
Earnings yield7.07%
Profitability
Operating margin (excl. other income)20.01%
Operating margin (incl. other income)23.40%
EBITDA margin21.75%
Pre-tax margin13.12%
Net profit margin9.90%
Net margin, latest quarter9.02%
ROE24.87%
ROCE26.21%
ROA10.27%
ROE, 3-year average25.73%
ROCE, 3-year average26.77%
ROA, 3-year average10.87%
ROIC (approx.)41.17%
Tax rate26.35%
Other income / net worth5.57%
Growth
Sales growth (latest year)5.55%
Profit growth (latest year)39.97%
Sales CAGR, 3 years17.08%
Profit CAGR, 3 years45.01%
Sales growth QoQ5.13%
Profit growth QoQ4.40%
Sales growth YoY (latest quarter)32.75%
Profit growth YoY (latest quarter)33.44%
Per share
EPS (TTM)Rs 12.51
EPS (latest year)Rs 5.53
EPS (latest quarter)Rs 2.95
EPS, 3-year averageRs 26.55
Book value per shareRs 28.87
Sales per shareRs 126.42
Cash flow per shareRs 5.06
Free cash flow per shareRs 0.69
Efficiency
Asset turnover0.74x
Fixed asset turnover1.78x
Inventory turnover18.82x
Inventory days19 days
Debtor days90 days
Debtors turnover4.06x
Creditor days156 days
Cash conversion cycle-12 days
Working capital days19 days
Leverage
Total debtRs 17 Cr
Cash and bankRs 9 Cr
Net debtRs 9 Cr
Debt to equity0.41x
Net debt / EBITDA0.22x
Interest coverage6.73x
Owners' fund to total sources44.81%
Debt to assets18.41%
Cash flow
Cash from Operating Activity (latest year)Rs 7 Cr
Cash from Investing Activity (latest year)Rs -21 Cr
Cash from Financing Activity (latest year)Rs 15 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 7 Cr
Cash from ops / profit, 5 years1.24x
Sales to cash flow9.39x
Statement figures
Net sales (TTM)Rs 183 Cr
Net sales (latest year)Rs 69 Cr
Sales (latest quarter)Rs 47 Cr
Operating profit excl. other income (latest year)Rs 14 Cr
Operating profit (latest quarter)Rs 9 Cr
Other income (TTM)Rs 4 Cr
EBITDA (TTM)Rs 40 Cr
PBDT (TTM)Rs 36 Cr
Profit before tax (TTM)Rs 24 Cr
Tax (latest year)Rs 3 Cr
Net profit (TTM)Rs 18 Cr
Net profit (latest year)Rs 8 Cr
Net profit (latest quarter)Rs 4 Cr
Depreciation (TTM)Rs 12 Cr
Depreciation (latest quarter)Rs 3 Cr
Interest (TTM)Rs 4 Cr
Cost of goods sold (latest year)Rs 27 Cr
Total expenditure (latest year)Rs 55 Cr
Total income (latest year)Rs 71 Cr
Share capitalRs 14 Cr
ReservesRs 27 Cr
Shareholders' fundsRs 42 Cr
Total assetsRs 93 Cr
Net blockRs 39 Cr
Capital work in progressRs 18 Cr
ReceivablesRs 17 Cr
InventoryRs 1 Cr
Other liabilitiesRs 34 Cr
Shares outstanding (crore)1.45
Ownership
Promoter holding61.17% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 14.2 is at the 5th percentile of its own 3.3-year range
(median 23.4, low 13.6, high 72.8).
P/B 6.13 is at the 12th percentile (median 8.46).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 543943 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +6.6% | -2.8% | +9.4 pts |
| 1 month | -17.7% | -6.8% | -10.9 pts |
| 3 months | -21.4% | -7.6% | -13.8 pts |
| 3 years | +60.7% | +14.2% | +46.5 pts |
Red flags
F-score 4 of 8| explain | Receivables outrunning sales Receivables grew 218% vs sales +6% in 2026 |
| explain | Share dilution Share count up 1108% in a year, 1108% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹47 Cr +32.8% vs Jun 2025.
Net profit ₹4 Cr +33.4%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Asarfi Hospital Ltd?
Asarfi Hospital Ltd (543943) has a market capitalisation of Rs 372 Cr. at the 2026-10-01 close.
What is the P/E ratio of Asarfi Hospital Ltd?
Asarfi Hospital Ltd trades at a P/E of 20.5 on trailing twelve-month profit, at the 2026-10-01 close.
What were Asarfi Hospital Ltd's latest quarterly results?
In the Jun 2026 quarter, Asarfi Hospital Ltd sales was Rs 47 Cr (+32.8% vs Jun 2025) and net profit was Rs 4 Cr.